Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Hachulla

Showing results (491-500 of 506) with videos related to

Pageof 51
Sort By:
Clinical and Experimental Rheumatology|May 17, 2022
Venous thromboembolism during systemic inflammatory and autoimmune diseases associated with myelodysplastic syndromes, chronic myelomonocytic leukaemia and myelodysplastic/myeloproliferative neoplasms: a French multicentre retrospective case-control studyMarie Péan de Ponfilly-Sotier, Vincent Jachiet, Ygal Benhamou, et al.
Annals of the Rheumatic Diseases|November 5, 2016
Development of the autoinflammatory disease damage index (ADDI)Nienke M Ter Haar, Kim V Annink, Sulaiman M Al-Mayouf, et al.
Nature Reviews. Rheumatology|January 7, 2021
The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNETRosaria Talarico, Silvia Aguilera, Tobias Alexander, et al.
Arthritis Care & Research|August 29, 2023
Impact of Risk Factors on COVID-19 Outcomes in Unvaccinated People With Rheumatic Diseases: A Comparative Analysis of Pandemic Epochs Using the COVID-19 Global Rheumatology Alliance RegistryJinoos Yazdany, Anna Ware, Zachary S Wallace, et al.
Nature Reviews. Rheumatology|October 6, 2022
Publisher Correction: The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNETRosaria Talarico, Silvia Aguilera, Tobias Alexander, et al.
RMD Open|October 29, 2015
EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guideRaphaèle Seror, Simon J Bowman, Pilar Brito-Zeron, et al.
Annals of the Rheumatic Diseases|August 6, 2018
In silico validation of the Autoinflammatory Disease Damage IndexNienke M Ter Haar, Amber Laetitia Justine van Delft, Kim Valerie Annink, et al.
Journal of Scleroderma and Related Disorders|November 15, 2024
Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients' care pathwayRosaria Talarico, Diana Marinello, Ilaria Palla, et al.
Autoimmunity Reviews|April 25, 2017
International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosusJean-François Kleinmann, Florence Tubach, Véronique Le Guern, et al.
Rheumatology (Oxford, England)|December 6, 2017
Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational StudySébastien Peytrignet, Christopher P Denton, Mark Lunt, et al.
Pageof 51

Showing results (491-500 of 506) with videos related to

Sort By:
Pageof 51
Clinical and Experimental Rheumatology|May 17, 2022
Venous thromboembolism during systemic inflammatory and autoimmune diseases associated with myelodysplastic syndromes, chronic myelomonocytic leukaemia and myelodysplastic/myeloproliferative neoplasms: a French multicentre retrospective case-control studyMarie Péan de Ponfilly-Sotier, Vincent Jachiet, Ygal Benhamou, et al.
Annals of the Rheumatic Diseases|November 5, 2016
Development of the autoinflammatory disease damage index (ADDI)Nienke M Ter Haar, Kim V Annink, Sulaiman M Al-Mayouf, et al.
Nature Reviews. Rheumatology|January 7, 2021
The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNETRosaria Talarico, Silvia Aguilera, Tobias Alexander, et al.
Arthritis Care & Research|August 29, 2023
Impact of Risk Factors on COVID-19 Outcomes in Unvaccinated People With Rheumatic Diseases: A Comparative Analysis of Pandemic Epochs Using the COVID-19 Global Rheumatology Alliance RegistryJinoos Yazdany, Anna Ware, Zachary S Wallace, et al.
Nature Reviews. Rheumatology|October 6, 2022
Publisher Correction: The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNETRosaria Talarico, Silvia Aguilera, Tobias Alexander, et al.
RMD Open|October 29, 2015
EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guideRaphaèle Seror, Simon J Bowman, Pilar Brito-Zeron, et al.
Annals of the Rheumatic Diseases|August 6, 2018
In silico validation of the Autoinflammatory Disease Damage IndexNienke M Ter Haar, Amber Laetitia Justine van Delft, Kim Valerie Annink, et al.
Journal of Scleroderma and Related Disorders|November 15, 2024
Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients' care pathwayRosaria Talarico, Diana Marinello, Ilaria Palla, et al.
Autoimmunity Reviews|April 25, 2017
International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosusJean-François Kleinmann, Florence Tubach, Véronique Le Guern, et al.
Rheumatology (Oxford, England)|December 6, 2017
Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational StudySébastien Peytrignet, Christopher P Denton, Mark Lunt, et al.
Pageof 51